What were the key financial metrics (revenue, net loss, cash flow) for Q2 2025, and how do they compare to prior quarters and consensus estimates?
Answer – Key financial metrics for Q2 2025 (based on the excerpt you provided)
| Metric | Q2 2025 (as reported) | Comparison to prior period | Comparison to consensus / analysts’ expectations |
|---|---|---|---|
| Revenue | Not disclosed in the excerpt | – | – |
| Net loss | Not disclosed in the excerpt | – | – |
| Cash flow (operating cash flow, free cash flow, or cash balance) | Not disclosed in the excerpt | – | – |
Why the numbers aren’t available here
The snippet you shared from Business Wire only mentions that agilon health announced its Q2 2025 results and that there was a leadership transition (Steven Sell stepped down and Ronald A. Williams moved to Executive Chairman). The summary cuts off before any financial figures (revenue amount, net loss amount, cash‑flow numbers, or any discussion of prior‑quarter or consensus comparisons) are given.
What you can do next
Locate the full press release – The complete Q2 2025 earnings release (usually titled “agilon health Reports Second Quarter 2025 Results” or similar) will contain a table of the key metrics:
- Revenue (both GAAP and non‑GAAP, if reported).
- Net loss (both GAAP and adjusted).
- Operating cash flow and/or free cash flow (and the cash balance at period‑end).
- Year‑over‑year (YoY) and quarter‑over‑quarter (QoQ) changes versus Q1 2025 and Q2 2024.
- Management commentary on whether the results met, beat, or missed Wall Street consensus estimates (usually supplied by FactSet, Bloomberg, Refinitiv, etc.).
- Revenue (both GAAP and non‑GAAP, if reported).
Check consensus estimates – Analyst consensus (often found in the “Earnings Outlook” section of the release or from investment‑bank research) will provide:
- Revenue estimate (e.g., $ X million) with a range or standard deviation.
- Adjusted EBITDA or net loss guidance (if provided).
- Revenue estimate (e.g., $ X million) with a range or standard deviation.
Compare the numbers – Once you have the actual values:
- Revenue: Compare the reported revenue to the consensus figure (e.g., “Revenue of $ X M, versus consensus estimate of $ Y M, a Z% beat/miss”).
- Net loss: Note the total net loss and whether it was higher or lower than analysts’ expected loss (e.g., “Net loss of $ X M versus consensus expectation of $ Y M”).
- Cash flow: Identify whether operating cash flow turned positive/negative and how that compares to prior quarters (e.g., “Operating cash flow of $ X M, up vs. $ Y M in Q1 2025, and slightly ahead of consensus $ Z M”).
- Provide the context – Usually you’ll want to add:
- YoY change (e.g., “Revenue grew 12% YoY”).
- QoQ change (e.g., “Revenue rose 5% from Q1 2025”).
- Key driver comments (e.g., “Growth driven by new Medicaid contracts and expanded virtual care”), as mentioned in the management discussion.
- YoY change (e.g., “Revenue grew 12% YoY”).
Bottom line
Because the current excerpt does not contain those financial figures, I cannot give you the precise revenue, net‑loss, or cash‑flow numbers for Q2 2025, nor the comparison to prior quarters or consensus estimates. To answer the question fully, you’ll need to consult the full agilon health Q2 2025 earnings release (available on the company’s investor‑relations website or via a detailed Business Wire/press‑release source) and then perform the comparison described above. If you locate the full numbers and share them, I can provide a detailed analysis and comparison for you.